Pilot trial to prevent type I diabetes: progression to overt IDDM despite oral nicotinamide

J Autoimmun. 1989 Oct;2(5):733-7. doi: 10.1016/s0896-8411(89)80011-3.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Administration, Oral
  • Autoantibodies / analysis
  • Autoimmune Diseases / drug therapy*
  • Diabetes Mellitus, Type 1 / prevention & control*
  • Drug Evaluation
  • Humans
  • Islets of Langerhans / immunology
  • Niacinamide / administration & dosage
  • Niacinamide / therapeutic use*
  • Pilot Projects
  • Prediabetic State / drug therapy*
  • Prediabetic State / immunology

Substances

  • Autoantibodies
  • Niacinamide